Tag

publications – access to medicines
September 1, 2020ByIn

Report: What is fair pricing?

ECL-What-is-a-Fair-Price-Paper_final
Continue Reading
August 1, 2020ByIn

Position paper: Europe’s Pharmaceutical Strategy 

ECL-Pharma-Strategy-Position-Paper-August-2020
Continue Reading
July 28, 2020ByIn

Public consultation: Intellectual Property Action Plan 

IP-Action-Plan_Roadmap-feedback_submitted-29-July-2020
Continue Reading
July 13, 2020ByIn

Public consultation: Pilot project ‘Market Launch of Intentions of Centrally Authorised Products’

Launch-Consultation_submitted-on-13-July-2020
Continue Reading
July 1, 2020ByIn

Joint recommendations: Towards fair prices of medicines in Europe 

AIM-Fair-Pricing-Principles_July2020
Continue Reading
June 24, 2020ByIn

Public consultation: The Pharmaceutical Strategy Roadmap 

EU-Pharma-Strategy-consultation_Roadmap-feedback-and-online-survey-comb-September-2020
Continue Reading
March 3, 2020ByIn

Public consultation: Europe’s Beating Cancer Plan Roadmap 

ECL-BCP-roadmap-and-consultation-feedback-merged_2020
Continue Reading
June 28, 2019ByIn

Report: What’s next on transparency?

Transparency-resolution-A2M-TF-Position-paper-2019
Continue Reading
June 1, 2019ByIn

Public consultation: European Medicines Agency Regulatory Science to 2025 

EMA-Regulatory-Science-2025-ECL-submission
Continue Reading
December 18, 2018ByIn,

How the European Medicines Agency engages with medicine producers before they apply for authorisations

ECL-Comments-European-Ombudsman-EMA-inquiry-Dec-2018
Continue Reading
1 2 3 4 5